Iztok Dolenc

2.1k total citations
41 papers, 1.8k citations indexed

About

Iztok Dolenc is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Iztok Dolenc has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Cell Biology. Recurrent topics in Iztok Dolenc's work include Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (9 papers) and Signaling Pathways in Disease (8 papers). Iztok Dolenc is often cited by papers focused on Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (9 papers) and Signaling Pathways in Disease (8 papers). Iztok Dolenc collaborates with scholars based in Slovenia, Sweden and Germany. Iztok Dolenc's co-authors include Vito Türk, Boris Turk, Veronika Stoka, Joseph G. Bieth, Anka Ritonja, Tadeja Bevec, Igor Križaj, Tatjana Popović, Ingemar Björk and Wolfgang Baumeister and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Iztok Dolenc

41 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iztok Dolenc Slovenia 22 930 667 423 319 274 41 1.8k
Dorit K. Nägler Germany 20 664 0.7× 657 1.0× 402 1.0× 229 0.7× 220 0.8× 33 1.5k
Jiuru Sun Australia 20 907 1.0× 430 0.6× 243 0.6× 195 0.6× 657 2.4× 28 1.8k
Gilles Gadéa France 25 1.5k 1.6× 376 0.6× 701 1.7× 792 2.5× 239 0.9× 46 2.8k
Pam M. Dando United Kingdom 10 629 0.7× 325 0.5× 354 0.8× 124 0.4× 249 0.9× 10 1.2k
Joseph T. Bruder United States 28 2.6k 2.8× 401 0.6× 795 1.9× 324 1.0× 601 2.2× 53 3.7k
Joachim Lipp Austria 21 1.2k 1.3× 442 0.7× 234 0.6× 219 0.7× 738 2.7× 31 2.0k
T Nakagawa United States 15 1.4k 1.5× 385 0.6× 200 0.5× 146 0.5× 917 3.3× 18 2.6k
Jung Hwa Kim South Korea 24 1.5k 1.6× 223 0.3× 401 0.9× 173 0.5× 216 0.8× 35 1.9k
C. Fernandez-Catalan Germany 12 890 1.0× 758 1.1× 651 1.5× 396 1.2× 99 0.4× 14 1.7k
Santiago Cal Spain 27 1.5k 1.6× 789 1.2× 695 1.6× 184 0.6× 341 1.2× 59 2.8k

Countries citing papers authored by Iztok Dolenc

Since Specialization
Citations

This map shows the geographic impact of Iztok Dolenc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iztok Dolenc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iztok Dolenc more than expected).

Fields of papers citing papers by Iztok Dolenc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iztok Dolenc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iztok Dolenc. The network helps show where Iztok Dolenc may publish in the future.

Co-authorship network of co-authors of Iztok Dolenc

This figure shows the co-authorship network connecting the top 25 collaborators of Iztok Dolenc. A scholar is included among the top collaborators of Iztok Dolenc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iztok Dolenc. Iztok Dolenc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dolenc, Iztok, Vito Türk, Ajda Taler‐Verčič, et al.. (2020). Human cathepsin X/Z is a biologically active homodimer. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1869(2). 140567–140567. 12 indexed citations
2.
Dolenc, Iztok, et al.. (2017). Tumor Necrosis Factor‐α Induced Apoptosis in U937 Cells Promotes Cathepsin D‐Independent Stefin B Degradation. Journal of Cellular Biochemistry. 118(12). 4813–4820. 6 indexed citations
3.
Türk, Vito, et al.. (2015). Aspartic cathepsin D degrades the cytosolic cysteine cathepsin inhibitor stefin B in the cells. Biochemical and Biophysical Research Communications. 465(2). 213–217. 9 indexed citations
4.
Dolenc, Iztok, Marko Mihelič, Tina Zavašnik‐Bergant, et al.. (2013). N-terminally truncated forms of human cathepsin F accumulate in aggresome-like inclusions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(10). 2254–2266. 14 indexed citations
5.
Puizdar, Vida, Eva Žerovnik, M. Renko, et al.. (2012). Biochemical characterization and structural modeling of human cathepsin E variant 2 in comparison to the wild-type protein. Biological Chemistry. 393(3). 177–186. 3 indexed citations
6.
Dolenc, Iztok, et al.. (2010). Baculoviral expression and characterization of human recombinant PGCP in the form of an active mature dimer and an inactive precursor protein. Protein Expression and Purification. 75(2). 119–126. 8 indexed citations
7.
Seemüller, Erika, Iztok Dolenc, & Andrei N. Lupas. (2004). Eukaryotic 20S Proteasome. Max Planck Institute for Plasma Physics. 2068–2077. 1 indexed citations
8.
Cimerman, Nina, et al.. (1999). Interaction of Cystatin C Variants with Papain and Human Cathepsins B, H and L. Journal of enzyme inhibition. 14(2). 167–174. 41 indexed citations
9.
Turk, Boris, Iztok Dolenc, Brigita Lenar≷cic̆, et al.. (1999). Acidic pH as a physiological regulator of human cathepsin L activity. European Journal of Biochemistry. 259(3). 926–932. 65 indexed citations
10.
Zühl, Frank, Tomohiro Tamura, Iztok Dolenc, et al.. (1997). Subunit topology of the Rhodococcus proteasome. FEBS Letters. 400(1). 83–90. 54 indexed citations
11.
Bevec, Tadeja, et al.. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.. The Journal of Experimental Medicine. 183(4). 1331–1338. 149 indexed citations
12.
Dolenc, Iztok, Boris Turk, Janko Kos, & Vito Türk. (1996). Interaction of human cathepsin C with chicken cystatin. FEBS Letters. 392(3). 277–280. 21 indexed citations
13.
Štrukelj, Borut, et al.. (1995). Molecular cloning and sequence analysis of human preprocathepsin C. FEBS Letters. 369(2-3). 326–330. 71 indexed citations
14.
Turk, Boris, Anka Ritonja, Ingemar Björk, et al.. (1995). Identification of bovine stefin A, a novel protein inhibitor of cysteine proteinases. FEBS Letters. 360(2). 101–105. 35 indexed citations
15.
Dolenc, Iztok, et al.. (1993). Purification of the complex of cathepsin L and the MHC class II‐associated invariant chain fragment from human kidney. FEBS Letters. 336(3). 555–559. 56 indexed citations
16.
Lenar≷cic̆, Brigita, Anka Ritonja, Boris Turk, Iztok Dolenc, & Vito Türk. (1992). Characterization and Structure of Pineapple Stem Inhibitor of Cysteine Proteinases. Biological Chemistry Hoppe-Seyler. 373(2). 459–464. 16 indexed citations
17.
Dolenc, Iztok, et al.. (1992). Bovine Cathepsins S and L: Isolation and Amino Acid Sequences. Biological Chemistry Hoppe-Seyler. 373(2). 407–412. 17 indexed citations
18.
Svetic, Branka, J Škrk, Marjan Budihna, et al.. (1992). Cathepsins B, H and L in human breast carcinoma.. PubMed. 30(2). 69–74. 53 indexed citations
19.
Ritonja, Anka, et al.. (1991). The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L. FEBS Letters. 283(2). 329–331. 23 indexed citations
20.
Kos, Janko, et al.. (1988). Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochemical and Biophysical Research Communications. 154(2). 765–772. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorit K. Nägler Breakdown of academic impact, for papers by Jiuru Sun Breakdown of academic impact, for papers by Gilles Gadéa Breakdown of academic impact, for papers by Pam M. Dando Breakdown of academic impact, for papers by Joseph T. Bruder Breakdown of academic impact, for papers by Joachim Lipp Breakdown of academic impact, for papers by T Nakagawa Breakdown of academic impact, for papers by Jung Hwa Kim Breakdown of academic impact, for papers by C. Fernandez-Catalan Breakdown of academic impact, for papers by Santiago Cal
Rankless by CCL
2026